SYT11 and acute myeloid leukemia: Notably, high SYT11 expression in other cancer types, such as Adrenocortical Cancer, Bladder Cancer, Acute Myeloid Leukemia, Mesothelioma, and Ocular Melanomas, also associated with poor prognoses (Fig. 9B–F).